Through their foundation and their personal giving, Gillian and Mike Goodrich have committed several gifts that will enable UAB to recruit a world-class pediatric cancer researcher, strengthen efforts to eliminate health and cancer disparities, and accelerate breast cancer research at UAB.
The mimicry of bone cells by multiple myeloma is driven by overexpression of Runx2, the master regulator of bone formation.
UAB offers two national clinical trials with customized treatment for lung cancer patients.
UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.
UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.
Pioneering cancer research at UAB will be presented at the American Society of Clinical Oncology meeting.
UAB researcher awarded first joint AACR- TNBC Foundation Career Development Award focused specifically on triple negative breast cancer.
Elevated PARP1 polymerase in HER2+ breast cancer may confer susceptibility to PARP inhibitor drugs.
The UAB Comprehensive Cancer Center’s April 30 Fiesta Ball at Iron City will fund the work of UAB’s young cancer research scientists.
Hot topics in cancer prevention and control to be highlighted at national ASPO meeting hosted by UAB.
Page 1 of 6